Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
Type:
Grant
Filed:
September 21, 2023
Date of Patent:
July 1, 2025
Assignee:
Ensovi, Inc.
Inventors:
Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
Type:
Grant
Filed:
November 2, 2022
Date of Patent:
May 14, 2024
Assignee:
Ensovi, Inc.
Inventors:
Kyle A Minor, Carlo D. Montemagno, David W. Wendell
Abstract: Described herein are engineered organelles comprising multi-component proteins from different species incorporated into a membrane structure with interior and exterior aspects. In one embodiment the artificial organelle incorporates one or more protein complexes that absorb optical energy and catalyze electron transfer in biochemical reactions that can be used to reduce NAD+ to NADH or analogues thereof.
Type:
Grant
Filed:
January 7, 2021
Date of Patent:
December 27, 2022
Assignee:
ENSOVI, INC.
Inventors:
Kyle A. Minor, Carlo D. Montemagno, David W. Wendell
© 2025 Justia
